These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2030601)

  • 1. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Bhalla K; McCrady C
    Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
    Heinemann V; Plunkett W
    Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of 1-beta-D-arabinofuranosylcytosine metabolism by hydroxyurea in human leukemic cell lines.
    Kubota M; Takimoto T; Tanizawa A; Akiyama Y; Mikawa H
    Biochem Pharmacol; 1988 May; 37(9):1745-9. PubMed ID: 2454114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K; MacLaughlin W; Cole J; Arlin Z; Baker M; Graham G; Grant S
    Blood; 1987 Aug; 70(2):568-71. PubMed ID: 3607288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
    Riva C; Barra Y; Carcassonne Y; Cano JP; Rustum Y
    Chemotherapy; 1992; 38(5):358-66. PubMed ID: 1286578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodeoxyuridine enhancement of 1-beta-D-arabinofuranosylcytosine metabolic activation and toxicity in HL-60 leukemic cells.
    Ross DD; Joneckis CC; Song TH; Wu RK
    Cancer Res; 1988 Feb; 48(3):517-21. PubMed ID: 3335018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroxyurea and thymidine derivatives on the uptake and metabolism of deoxycytidine and arabinofuranosylcytosine in log phase and contact-inhibited human diploid fibroblasts.
    Snyder RD; Malick NC
    Mol Pharmacol; 1985 Dec; 28(6):574-80. PubMed ID: 4079913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines.
    Noordhuis P; Kazemier KM; Kasperrs GJ; Peters GJ
    Leuk Res; 1996 Feb; 20(2):127-34. PubMed ID: 8628011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordant changes of pyrimidine metabolism in blasts of two cases of acute myeloid leukemia after repeated treatment with ara-C in vivo.
    Chiba P; Tihan T; Szekeres T; Salamon J; Kraupp M; Eher R; Köller U; Knapp W
    Leukemia; 1990 Nov; 4(11):761-5. PubMed ID: 2232889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Boise L; Westin E; Howe C; Pettit GR; Turner A; McCrady C
    Biochem Pharmacol; 1991 Jul; 42(4):853-67. PubMed ID: 1867641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.
    Zittoun J; Marquet J; David JC; Maniey D; Zittoun R
    Cancer Chemother Pharmacol; 1989; 24(4):251-5. PubMed ID: 2752506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1.
    Bhalla K; Cole J; MacLaughlin W; Baker M; Arlin Z; Graham G; Grant S
    Blood; 1986 Nov; 68(5):1136-41. PubMed ID: 3464321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
    White JC; Capizzi RL
    Cancer Res; 1991 May; 51(10):2559-65. PubMed ID: 2021937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
    Horber DH; Schott H; Schwendener RA
    Cancer Chemother Pharmacol; 1995; 36(6):483-92. PubMed ID: 7554040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
    Avramis VI; Powell W
    Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular dCTP/ara-CTP ratio and the cytotoxic effect of ara-C.
    Kawasaki H; Kuwabara H; Hori H; Higashigawa M; Ohkubo T; Sakurai M
    Cancer Invest; 1991; 9(4):409-13. PubMed ID: 1884247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Greer SB
    Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine.
    Horber DH; Schott H; Schwendener RA
    Br J Cancer; 1995 May; 71(5):957-62. PubMed ID: 7734320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J; Mortensen BT
    Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.